Detailed evaluation of the mechanism of action of GPR40 partial agonists in the GK rat model revealed that a reduction in EGP via decreased gluconeogenic flux underlies the observed reduction in hyperglycemia. Here, FFAR1 is linked to Hyperglycemia.